CUSIP 921659108COMVNDAQ4 2025
Aggregate 13F value by quarter
Multi-quarter trend — upgrade to see history
UpgradeQ4 2025
149 funds hold this security · Q4 2025
| # | Fund | Shares | Value | Δ Shares | Activity |
|---|---|---|---|---|---|
| 1 | Blackrock, Inc. | 7.77M | $68.56M | −1.14M | Reduced |
| 2 | Vanguard Group Inc | 3.73M | $32.91M | +144.7K | Added |
| 3 | Renaissance Technologies LLC | 3.38M | $29.82M | −96.0K | Reduced |
| 4 | Dimensional Fund Advisors LP | 2.12M | $18.68M |
| −445.5K |
| Reduced |
| 5 | Aigh Capital Management LLC | 2.00M | $17.63M | +2.00M | New |
| 6 | Millennium Management LLC | 1.68M | $14.81M | −1.57M | Reduced |
| 7 | Geode Capital Management, LLC | 1.39M | $12.28M | −295 | Reduced |
| 8 | State Street Corp | 1.26M | $11.14M | −7.5K | Reduced |
| 9 | Empire Financial Management Company, LLC | 1.11M | $9.77M | +350.2K | Added |
| 10 | Two Sigma Advisers, LP | 1.05M | $9.25M | +140.0K | Added |
See every fund holding Vanda Pharmaceuticals Inc, with full quarter-over-quarter share changes.
Unlock all holders